Autonomix Medical Future Growth
Future criteria checks 0/6
Autonomix Medical is forecast to grow earnings and revenue by 0% and 86.8% per annum respectively while EPS is expected to grow by 19.4% per annum.
Key information
0.0001%
Earnings growth rate
19.4%
EPS growth rate
| Medical Equipment earnings growth | 17.6% |
| Revenue growth rate | 86.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 25 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | N/A | -13 | N/A | -11 | 1 |
| 3/31/2026 | N/A | -14 | N/A | -10 | 1 |
| 3/31/2025 | N/A | -8 | N/A | -7 | 1 |
| 6/30/2024 | N/A | -17 | -8 | -8 | N/A |
| 3/31/2024 | N/A | -15 | -7 | -7 | N/A |
| 12/31/2023 | N/A | -11 | -5 | -5 | N/A |
| 9/30/2023 | N/A | -8 | -3 | -3 | N/A |
| 6/30/2023 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2023 | N/A | -2 | -2 | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMIX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AMIX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AMIX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AMIX is forecast to have no revenue next year.
High Growth Revenue: AMIX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AMIX's Return on Equity is forecast to be high in 3 years time